The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Budesonide Capsules-Global Market Insights and Sales Trends 2025
Synopsis
Budesonide is a first-line anti-inflammatory agent and locally acting glucocorticosteroid indicated for the induction and maintenance of remission of mild to moderate ileocaecal Crohn's disease (capsules) and ulcerative colitis (enemas) as well as for the remission of active microscopic colitis (capsules).
The global Budesonide Capsules market size is expected to reach US$ 1646.3 million by 2029, growing at a CAGR of 9.1% from 2023 to 2029. The market is mainly driven by the significant applications of Budesonide Capsules in various end use industries. The expanding demands from the Crohn's Disease, Collagenous Colitis and Autoimmune Hepatitis,, are propelling Budesonide Capsules market. 1mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 2mg segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Budesonide Capsules market, driven by demand from China, the second largest economy with some signs of stabilising, the Budesonide Capsules market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Budesonide Capsules, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Budesonide Capsules market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Budesonide Capsules market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Budesonide Capsules sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Budesonide Capsules covered in this report include Perrigo, Mylan, Tillotts Pharma, Teva, Zydus Pharmaceuticals, Amneal, Mayne Pharma and Sciecure Pharma, etc.
The global Budesonide Capsules market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Perrigo
Mylan
Tillotts Pharma
Teva
Zydus Pharmaceuticals
Amneal
Mayne Pharma
Sciecure Pharma
Global Budesonide Capsules market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Budesonide Capsules market, Segment by Type:
1mg
2mg
3mg
Global Budesonide Capsules market, by Application
Crohn's Disease
Collagenous Colitis
Autoimmune Hepatitis
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Budesonide Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Budesonide Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Budesonide is a first-line anti-inflammatory agent and locally acting glucocorticosteroid indicated for the induction and maintenance of remission of mild to moderate ileocaecal Crohn's disease (capsules) and ulcerative colitis (enemas) as well as for the remission of active microscopic colitis (capsules).
The global Budesonide Capsules market size is expected to reach US$ 1646.3 million by 2029, growing at a CAGR of 9.1% from 2023 to 2029. The market is mainly driven by the significant applications of Budesonide Capsules in various end use industries. The expanding demands from the Crohn's Disease, Collagenous Colitis and Autoimmune Hepatitis,, are propelling Budesonide Capsules market. 1mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 2mg segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Budesonide Capsules market, driven by demand from China, the second largest economy with some signs of stabilising, the Budesonide Capsules market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Budesonide Capsules, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Budesonide Capsules market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Budesonide Capsules market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Budesonide Capsules sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Budesonide Capsules covered in this report include Perrigo, Mylan, Tillotts Pharma, Teva, Zydus Pharmaceuticals, Amneal, Mayne Pharma and Sciecure Pharma, etc.
The global Budesonide Capsules market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Perrigo
Mylan
Tillotts Pharma
Teva
Zydus Pharmaceuticals
Amneal
Mayne Pharma
Sciecure Pharma
Global Budesonide Capsules market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Budesonide Capsules market, Segment by Type:
1mg
2mg
3mg
Global Budesonide Capsules market, by Application
Crohn's Disease
Collagenous Colitis
Autoimmune Hepatitis
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Budesonide Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Budesonide Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Budesonide Capsules Market Overview
1.1 Budesonide Capsules Product Overview
1.2 Budesonide Capsules Market Segment by Type
1.2.1 1mg
1.2.2 2mg
1.2.3 3mg
1.3 Global Budesonide Capsules Market Size by Type
1.3.1 Global Budesonide Capsules Market Size Overview by Type (2018-2029)
1.3.2 Global Budesonide Capsules Historic Market Size Review by Type (2018-2023)
1.3.3 Global Budesonide Capsules Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Budesonide Capsules Sales Breakdown by Type (2018-2023)
1.4.2 Europe Budesonide Capsules Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Budesonide Capsules Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Budesonide Capsules Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Budesonide Capsules Sales Breakdown by Type (2018-2023)
2 Global Budesonide Capsules Market Competition by Company
2.1 Global Top Players by Budesonide Capsules Sales (2018-2023)
2.2 Global Top Players by Budesonide Capsules Revenue (2018-2023)
2.3 Global Top Players by Budesonide Capsules Price (2018-2023)
2.4 Global Top Manufacturers Budesonide Capsules Manufacturing Base Distribution, Sales Area, Product Type
2.5 Budesonide Capsules Market Competitive Situation and Trends
2.5.1 Budesonide Capsules Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Budesonide Capsules Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Budesonide Capsules as of 2022)
2.7 Date of Key Manufacturers Enter into Budesonide Capsules Market
2.8 Key Manufacturers Budesonide Capsules Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Budesonide Capsules Status and Outlook by Region
3.1 Global Budesonide Capsules Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Budesonide Capsules Historic Market Size by Region
3.2.1 Global Budesonide Capsules Sales in Volume by Region (2018-2023)
3.2.2 Global Budesonide Capsules Sales in Value by Region (2018-2023)
3.2.3 Global Budesonide Capsules Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Budesonide Capsules Forecasted Market Size by Region
3.3.1 Global Budesonide Capsules Sales in Volume by Region (2024-2029)
3.3.2 Global Budesonide Capsules Sales in Value by Region (2024-2029)
3.3.3 Global Budesonide Capsules Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Budesonide Capsules by Application
4.1 Budesonide Capsules Market Segment by Application
4.1.1 Crohn's Disease
4.1.2 Collagenous Colitis
4.1.3 Autoimmune Hepatitis
4.2 Global Budesonide Capsules Market Size by Application
4.2.1 Global Budesonide Capsules Market Size Overview by Application (2018-2029)
4.2.2 Global Budesonide Capsules Historic Market Size Review by Application (2018-2023)
4.2.3 Global Budesonide Capsules Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Budesonide Capsules Sales Breakdown by Application (2018-2023)
4.3.2 Europe Budesonide Capsules Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Budesonide Capsules Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Budesonide Capsules Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Budesonide Capsules Sales Breakdown by Application (2018-2023)
5 North America Budesonide Capsules by Country
5.1 North America Budesonide Capsules Historic Market Size by Country
5.1.1 North America Budesonide Capsules Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Budesonide Capsules Sales in Volume by Country (2018-2023)
5.1.3 North America Budesonide Capsules Sales in Value by Country (2018-2023)
5.2 North America Budesonide Capsules Forecasted Market Size by Country
5.2.1 North America Budesonide Capsules Sales in Volume by Country (2024-2029)
5.2.2 North America Budesonide Capsules Sales in Value by Country (2024-2029)
6 Europe Budesonide Capsules by Country
6.1 Europe Budesonide Capsules Historic Market Size by Country
6.1.1 Europe Budesonide Capsules Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Budesonide Capsules Sales in Volume by Country (2018-2023)
6.1.3 Europe Budesonide Capsules Sales in Value by Country (2018-2023)
6.2 Europe Budesonide Capsules Forecasted Market Size by Country
6.2.1 Europe Budesonide Capsules Sales in Volume by Country (2024-2029)
6.2.2 Europe Budesonide Capsules Sales in Value by Country (2024-2029)
7 Asia-Pacific Budesonide Capsules by Region
7.1 Asia-Pacific Budesonide Capsules Historic Market Size by Region
7.1.1 Asia-Pacific Budesonide Capsules Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Budesonide Capsules Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Budesonide Capsules Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Budesonide Capsules Forecasted Market Size by Region
7.2.1 Asia-Pacific Budesonide Capsules Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Budesonide Capsules Sales in Value by Region (2024-2029)
8 Latin America Budesonide Capsules by Country
8.1 Latin America Budesonide Capsules Historic Market Size by Country
8.1.1 Latin America Budesonide Capsules Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Budesonide Capsules Sales in Volume by Country (2018-2023)
8.1.3 Latin America Budesonide Capsules Sales in Value by Country (2018-2023)
8.2 Latin America Budesonide Capsules Forecasted Market Size by Country
8.2.1 Latin America Budesonide Capsules Sales in Volume by Country (2024-2029)
8.2.2 Latin America Budesonide Capsules Sales in Value by Country (2024-2029)
9 Middle East and Africa Budesonide Capsules by Country
9.1 Middle East and Africa Budesonide Capsules Historic Market Size by Country
9.1.1 Middle East and Africa Budesonide Capsules Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Budesonide Capsules Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Budesonide Capsules Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Budesonide Capsules Forecasted Market Size by Country
9.2.1 Middle East and Africa Budesonide Capsules Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Budesonide Capsules Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Perrigo
10.1.1 Perrigo Company Information
10.1.2 Perrigo Introduction and Business Overview
10.1.3 Perrigo Budesonide Capsules Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Perrigo Budesonide Capsules Products Offered
10.1.5 Perrigo Recent Development
10.2 Mylan
10.2.1 Mylan Company Information
10.2.2 Mylan Introduction and Business Overview
10.2.3 Mylan Budesonide Capsules Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Mylan Budesonide Capsules Products Offered
10.2.5 Mylan Recent Development
10.3 Tillotts Pharma
10.3.1 Tillotts Pharma Company Information
10.3.2 Tillotts Pharma Introduction and Business Overview
10.3.3 Tillotts Pharma Budesonide Capsules Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Tillotts Pharma Budesonide Capsules Products Offered
10.3.5 Tillotts Pharma Recent Development
10.4 Teva
10.4.1 Teva Company Information
10.4.2 Teva Introduction and Business Overview
10.4.3 Teva Budesonide Capsules Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Teva Budesonide Capsules Products Offered
10.4.5 Teva Recent Development
10.5 Zydus Pharmaceuticals
10.5.1 Zydus Pharmaceuticals Company Information
10.5.2 Zydus Pharmaceuticals Introduction and Business Overview
10.5.3 Zydus Pharmaceuticals Budesonide Capsules Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Zydus Pharmaceuticals Budesonide Capsules Products Offered
10.5.5 Zydus Pharmaceuticals Recent Development
10.6 Amneal
10.6.1 Amneal Company Information
10.6.2 Amneal Introduction and Business Overview
10.6.3 Amneal Budesonide Capsules Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Amneal Budesonide Capsules Products Offered
10.6.5 Amneal Recent Development
10.7 Mayne Pharma
10.7.1 Mayne Pharma Company Information
10.7.2 Mayne Pharma Introduction and Business Overview
10.7.3 Mayne Pharma Budesonide Capsules Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Mayne Pharma Budesonide Capsules Products Offered
10.7.5 Mayne Pharma Recent Development
10.8 Sciecure Pharma
10.8.1 Sciecure Pharma Company Information
10.8.2 Sciecure Pharma Introduction and Business Overview
10.8.3 Sciecure Pharma Budesonide Capsules Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sciecure Pharma Budesonide Capsules Products Offered
10.8.5 Sciecure Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Budesonide Capsules Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Budesonide Capsules Industrial Chain Analysis
11.4 Budesonide Capsules Market Dynamics
11.4.1 Budesonide Capsules Industry Trends
11.4.2 Budesonide Capsules Market Drivers
11.4.3 Budesonide Capsules Market Challenges
11.4.4 Budesonide Capsules Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Budesonide Capsules Distributors
12.3 Budesonide Capsules Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
